Uncategorized

Collegium Pharmaceutical Inc (NASDAQ:COLL) Given Average Recommendation of “Buy” by Analysts

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stocks Recorder

Democratizing access to all financial data. Cutting edge web platform for news and information.

About Stocks Recorder

Disclaimer: Stocks Recorder inform you that the data in this website is not necessarily real-time nor accurate. All prices are not provided by exchanges and prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Stocks Recorder doesn`t bear any responsibility for any trading losses you might incur as a result of using the data.

Subscribe
Stocks Recorder

ALL RIGHTS RESERVED © 2019 STOCKRECORDER